Description
The AirWave technology is a personalized, non-invasive solution for patients with respiratory conditions such as COVID-19, pneumonia, or chronic lung disease. It uses sound waves to gently vibrate the lungs and airways, helping loosen and clear mucus that makes breathing difficult. The technology has several key advantages, including patient-specific customization, targeted therapy, higher efficiency, and non-invasive approach. The market applications for this technology include hospitals and healthcare systems, medical device manufacturers, pulmonary rehabilitation centers, home healthcare providers, critical care and emergency medicine, telehealth and remote monitoring companies, pharmaceutical and biotech firms, and military and government health agencies.
• Patient-specific customization through CT scans and modeling
• Targeted therapy to specific problem areas in the lungs
• Higher efficiency using higher-frequency sound waves
• Non-invasive approach without surgical procedures or invasive devices
• Multiple delivery methods, including through the mouth or externally using acoustic transducers, speakers, or shakers
• Improved patient outcomes through faster mucus clearance and reduced complications
• Broad clinical applications for conditions like COVID-19, pneumonia, and chronic lung diseases
• Commercial potential as a scalable solution for hospitals and respiratory care providers worldwide
Attached files
Contact
Satya Srinivasan